Study of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative Neoplasms

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative Neoplasms	Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, myeloproliferative neoplasm	Recruiting	Phase 2	2026-07-06		NCT05074355

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University Health Network, Toronto	417

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Princess Margaret Cancer Centre	Toronto	Canada	145

Clinical trials